![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 413/14 | (2006.01) | ||
A61K 31/415 | (2006.01) | ||
A61K 31/454 | (2006.01) | ||
A61K 31/4709 | (2006.01) | ||
A61K 31/497 | (2006.01) | ||
A61K 31/506 | (2006.01) | ||
C07D 231/14 | (2006.01) | ||
C07D 401/06 | (2006.01) | ||
C07D 401/10 | (2006.01) | ||
C07D 403/10 | (2006.01) | ||
C07D 409/14 | (2006.01) |
(11) | Patento numeris | 3556752 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19176610.4 |
Europos patento paraiškos padavimo data | 2015-11-26 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-10-23 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-01-05 |
(46) | Apibrėžties vertimo paskelbimo data | 2022-03-10 |
(30) | Numeris | Data | Šalis |
201421083 | 2014-11-27 | GB |
(72) |
DAVIE, Rebecca Louise , GB
EDWARDS, Hannah Joy , GB
EVANS, David Michael , GB
HODGSON, Simon Teanby , GB
|
(73) |
Kalvista Pharmaceuticals Limited ,
Porton Science Park
Bybrook Road, Porton Down, Salisbury SP4 0BF
Wiltshire,
GB
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | N-((het)arilmetil)-heteroaril-karboksamidų junginiai kaip plazmos kalikreino inhibitoriai |
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS |
Mokėjimo data | Galiojimo metai | Suma | |
2024-10-24 | 10 | 231.00 EUR |
2025-11-26 |